Youmanitarian
11 Jun 2021
PARP Inhibitors for Maintenance Therapy in Ovarian Cancer
18 vistas
TAKE ACTION
Donations would go to support charities for
Cómo hacer y estilo
PARP, or poly-ADP ribose polymerase, inhibitors block repair of damaged DNA in tumor cells which increases cell death, especially in tumors with deficient repair mechanisms. One of the most recent important advances ovarian cancer treatment, PARP inhibitors have improved progression-free survival and are now being approved for first-line maintenance therapy in advanced stage disease. Several additional large-scale trials are underway with PARP inhibitors set to make great strides in improving outcomes in cancer therapy.
Mostrar más
More ways to take action
Explore ways that you can help bring a solution to this issue.
Create Youms with hashtags Cómo hacer y estilo
Create a challenge to bring awareness to this issue for people to complete
Create a fundraiser to support a charity that tackle this issue
Volunteer at charitable organization that support this cause
Create a movement page dedicated to this cause to bring awareness.
Start a uCharity for this cause and invite people to join it to support this cause
